Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Norwegian government awards grant to Bionor

July 10, 2012

Bristol-Myers Squibb prepares new HIV attachment inhibitors

July 5, 2012

Novel chemokine receptor antagonists patented by Emory University

July 4, 2012

Gilead submits NDA to FDA for AIDS drug

July 2, 2012

Gilead submits NDA for elvitegravir

June 29, 2012

Theratechnologies gives update on tesamorelin regulatory progress

June 25, 2012

Novel agents for AIDS prepared at Pfizer

June 20, 2012

EMA to conduct centralized review of elvitegravir MAA

June 19, 2012

Katholieke Universiteit Leuven patents novel agents for HIV

June 15, 2012

Chinese researchers develop new vaccines

June 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...